Taigen Biopharmaceuticals Holdings Ltd (4157) — Cash Flow-to-Debt Ratio
Taigen Biopharmaceuticals Holdings Ltd (4157) has a Cash Flow-to-Debt Ratio of -1.09x as of June 2026, meaning its operating cash flow of NT$-41.33 Million could theoretically repay -1% of its total liabilities (NT$37.84 Million) in one year. See Taigen Biopharmaceuticals Holdings Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Taigen Biopharmaceuticals Holdings Ltd Cash Flow-to-Debt Ratio (2010–2025)
Historical debt coverage capacity for Taigen Biopharmaceuticals Holdings Ltd across 16 annual periods. For the full cash flow conversion analysis, see 4157 operating cash flow.
Annual Cash Flow-to-Debt Ratio for Taigen Biopharmaceuticals Holdings Ltd (2010–2025)
Year-by-year debt coverage analysis for Taigen Biopharmaceuticals Holdings Ltd. Check earnings quality score of Taigen Biopharmaceuticals Holdings Ltd to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.23x | NT$20.93 Million | NT$92.38 Million | ▲ +112.0% |
| 2024 | -1.88x | NT$-173.09 Million | NT$91.96 Million | ▼ -1106.8% |
| 2023 | 0.19x | NT$20.74 Million | NT$110.94 Million | ▲ +167.7% |
| 2022 | -0.28x | NT$-21.27 Million | NT$76.98 Million | ▼ -106.1% |
| 2021 | 4.52x | NT$629.07 Million | NT$139.11 Million | ▲ +313.4% |
| 2020 | -2.12x | NT$-242.10 Million | NT$114.26 Million | ▲ +19.0% |
| 2019 | -2.62x | NT$-342.52 Million | NT$130.92 Million | ▲ +3.2% |
| 2018 | -2.70x | NT$-254.93 Million | NT$94.36 Million | ▲ +1.1% |
| 2017 | -2.73x | NT$-266.93 Million | NT$97.71 Million | ▼ -164.2% |
| 2016 | -1.03x | NT$-152.83 Million | NT$147.82 Million | ▲ +67.9% |
| 2015 | -3.22x | NT$-592.56 Million | NT$183.86 Million | ▼ -46.8% |
| 2014 | -2.19x | NT$-540.03 Million | NT$246.05 Million | ▼ -59.3% |
| 2013 | -1.38x | NT$-458.46 Million | NT$332.71 Million | ▼ -252.0% |
| 2012 | -0.39x | NT$-141.36 Million | NT$361.15 Million | ▲ +90.0% |
| 2011 | -3.90x | NT$-379.23 Million | NT$97.31 Million | ▼ -10617.6% |
| 2010 | -0.04x | NT$-196.43 Million | NT$5.40 Billion | — |